Paragon pads its exec ranks; Catalent amps up a German plant;

> Contract drug developer Paragon Bioservices has appointed four new vice presidents, following up on its October financing round and plotting to expand its share of the market. More

> Catalent is adding new technology to a German plant focused on softgel manufacturing. News

> BioClinica has added three mid-sized biotechs to its roster of data-management clients. Item